Tandem Diabetes Care Inc
NASDAQ:TNDM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Tandem Diabetes Care Inc
Tandem Diabetes Care Inc
Accounts Receivables
Tandem Diabetes Care Inc
Accounts Receivables Peer Comparison
BSX
SYK
ABT
ISRG
SWAV
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Accounts Receivables
$93m
|
CAGR 3-Years
8%
|
CAGR 5-Years
23%
|
CAGR 10-Years
39%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Receivables
$3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Receivables
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Accounts Receivables
$124.4m
|
CAGR 3-Years
85%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
See Also
What is Tandem Diabetes Care Inc's Accounts Receivables?
Accounts Receivables
93m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Accounts Receivables amounts to 93m USD.
What is Tandem Diabetes Care Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
39%
Over the last year, the Accounts Receivables growth was 2%. The average annual Accounts Receivables growth rates for Tandem Diabetes Care Inc have been 8% over the past three years , 23% over the past five years , and 39% over the past ten years .
You don't have any saved screeners yet
